KP Pharmaceutical Technology, Inc.

Form 483 issued February 3, 2023 · Bloomington, Indiana

Inspection
Jan 30 – Feb 3, 2023
Observations
2
Pages
4
FEI number
3001802820

In short: On February 3, 2023, FDA issued a Form 483 with 2 observations to KP Pharmaceutical Technology, Inc. in Bloomington, Indiana (FEI 3001802820) after an inspection that ran Jan 30 – Feb 3, 2023. The investigators were Logan T. Williams and Rafeeq Habeeb. The most-cited regulation is 21 CFR 212.20 (what activities must I perform to ensure drug quality?).

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    You did not establish and follow…

  2. 02

    You did not implement procedures and document your activities in accordance with your procedures to ensure…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at KP Pharmaceutical Technology, Inc.?

FDA listed 2 observations on this Form 483. The most-cited regulation is 21 CFR 212.20 (what activities must I perform to ensure drug quality?). The opening words of each observation are shown on this page.

Who inspected KP Pharmaceutical Technology, Inc.?

Logan T. Williams and Rafeeq Habeeb are named on this Form 483, for the inspection of Jan 30 – Feb 3, 2023. Each investigator has a profile showing what they cite most.

When was KP Pharmaceutical Technology, Inc. inspected by FDA?

The inspection ran Jan 30 – Feb 3, 2023, and the Form 483 is dated February 3, 2023.

How do I get the full Form 483 for KP Pharmaceutical Technology, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free